FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jose Teixeira

Research Profile

Chemicals & Drugs

Living Beings

Mouse
Rats

Anatomy

Disorders

Ovarian Neoplasms

Physiology

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Katia Meirelles; David Pepin; Frederic Preffer; Pradeep Singh Tanwar; Jose Teixeira; Leo Andrew Benedict; David Dombkowski; Patricia K Donahoe; David T MacLaughlin; Robert H Young; Xiaolong Wei
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.
Xiaolong Wei; David Dombkowski; Katia Meirelles; Rafael Pieretti-Vanmarcke; Paul P Szotek; Henry L Chang; Frederic Preffer; Peter R Mueller; Jose Teixeira; David T MacLaughlin; Patricia K Donahoe
Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics.
Thanos D Papakostas; Rafael Pieretti-Vanmarcke; Fotini Nicolaou; Aristomenis Thanos; George Trichonas; Xanthi Koufomichali; Kosisochukwu Anago; Patricia K Donahoe; Jose Teixeira; David T MacLaughlin; Demetrios Vavvas
Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jose Teixeira (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Katia Meirelles; David Pepin; Frederic Preffer; Pradeep Singh Tanwar; Jose Teixeira; Leo Andrew Benedict; David Dombkowski; Patricia K Donahoe; David T MacLaughlin; Robert H Young; Xiaolong Wei
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(7):2358-63.
2010: Xiaolong Wei; David Dombkowski; Katia Meirelles; Rafael Pieretti-Vanmarcke; Paul P Szotek; Henry L Chang; Frederic Preffer; Peter R Mueller; Jose Teixeira; David T MacLaughlin; Patricia K Donahoe
Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(44):18874-9.
2010: Thanos D Papakostas; Rafael Pieretti-Vanmarcke; Fotini Nicolaou; Aristomenis Thanos; George Trichonas; Xanthi Koufomichali; Kosisochukwu Anago; Patricia K Donahoe; Jose Teixeira; David T MacLaughlin; Demetrios Vavvas
Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.
Protein expression and purification 2010;70(1):32-8.
2010: Henry L Chang; Tharanga N Senaratne; Lihua Zhang; Paul P Szotek; Ethan Stewart; David Dombkowski; Frederic Preffer; Patricia K Donahoe; Jose Teixeira
Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometrium.
Reproductive sciences (Thousand Oaks, Calif.) 2010;17(2):158-67.
2008: Paul P Szotek; Henry L Chang; Kristen Brennand; Akihiro Fujino; Rafael Pieretti-Vanmarcke; Cristina Lo Celso; David Dombkowski; Frederic Preffer; Kenneth S Cohen; Jose Teixeira; Patricia K Donahoe
Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(34):12469-73.
2008: Nina Renlund; Rafael Pieretti-Vanmarcke; Francis O'Neill; LiHua Zhang; Patricia K Donahoe; Jose Teixeira
c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction.
Endocrinology 2008;149(1):108-15.
2007: Nina Renlund; Francis O'Neill; LiHua Zhang; Yisrael Sidis; Jose Teixeira
Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.
The Journal of endocrinology 2007;195(1):95-103.
2007: Paul P Szotek; Henry L Chang; LiHua Zhang; Frederic Preffer; David Dombkowski; Patricia K Donahoe; Jose Teixeira
Adult mouse myometrial label-retaining cells divide in response to gonadotropin stimulation.
Stem cells (Dayton, Ohio) 2007;25(5):1317-25.
2006: Yong Zhan; Akihiro Fujino; David T MacLaughlin; Thomas F Manganaro; Paul P Szotek; Nelson A Arango; Jose Teixeira; Patricia K Donahoe
Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Development (Cambridge, England) 2006;133(12):2359-69.
2005: Nelson A Arango; Paul P Szotek; Thomas F Manganaro; Esther Oliva; Patricia K Donahoe; Jose Teixeira
Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium.
Developmental biology 2005;288(1):276-83.
2004: Nelson A Arango; Elliot J Pearson; Patricia K Donahoe; Jose Teixeira
Genomic structure and expression analysis of the mouse testis-specific ribbon protein (Trib) gene.
Gene 2004;343(1):221-7.
2004: Alexander M Trbovich; Nina Martinelle; Francis O'Neill; Elliot J Pearson; Patricia K Donahoe; patrick sluss; Jose Teixeira
Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance.
The Journal of steroid biochemistry and molecular biology 2004;92(3):199-208.
2004: Christopher P. Houk; Elliot J Pearson; Nina Martinelle; Patricia K Donahoe; Jose Teixeira
Feedback inhibition of steroidogenic acute regulatory protein expression in vitro and in vivo by androgens.
Endocrinology 2004;145(3):1269-75.
2003: Eric Fynn-Thompson; Henry Cheng; Jose Teixeira
Inhibition of steroidogenesis in Leydig cells by Müllerian-inhibiting substance.
Molecular and cellular endocrinology 2003;211(1-2):99-104.
2003: Patricia K Donahoe; Trent Clarke; Jose Teixeira; Shyamala Maheswaran; David T MacLaughlin
Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
Molecular and cellular endocrinology 2003;211(1-2):37-42.
2003: Grégoy Y Bédécarrats; Francis O'Neill; Errol R Norwitz; Ursula B Kaiser; Jose Teixeira
Regulation of gonadotropin gene expression by Mullerian inhibiting substance.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(16):9348-53.
2002: V Matt Laurich; Alexander M Trbovich; Francis O'Neill; Christopher P. Houk; patrick sluss; Anita H Payne; Patricia K Donahoe; Jose Teixeira
Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.
Endocrinology 2002;143(9):3351-60.
2002: Hans Lorenzo; Jose Teixeira; Nima Pahlavan; V Matt Laurich; Patricia K Donahoe; David T MacLaughlin
New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2002;766(1):89-98.
2001: Jose Teixeira; Shyamala Maheswaran; Patricia K Donahoe
Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.
Endocrine reviews 2001;22(5):657-74.
2001: Alexander M Trbovich; patrick sluss; V Matt Laurich; Francis O'Neill; David T MacLaughlin; Patricia K Donahoe; Jose Teixeira
Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3393-7.
1999: Jose Teixeira; DJ Kehas; R Antun; Patricia K Donahoe
Transcriptional regulation of the rat Müllerian inhibiting substance type II receptor in rodent Leydig cells.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(24):13831-8.
1999: Peter T Masiakos; David T MacLaughlin; Shyamala Maheswaran; Jose Teixeira; Arlan F Fuller; P C Shah; DJ Kehas; M K Kenneally; David Dombkowski; Thanh U Ha; Frederic Preffer; Patricia K Donahoe
Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3488-99.
1999: Jose Teixeira; E Fynn-Thompson; A H Payne; Patricia K Donahoe
Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
Endocrinology 1999;140(10):4732-8.
1997: E A Catlin; V C Tonnu; R G Ebb; BA Pacheco; Thomas F Manganaro; Robert Ezzell; Patricia K Donahoe; Jose Teixeira
Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.
Endocrinology 1997;138(2):790-6.
1996: Jose Teixeira; W W He; P C Shah; N Morikawa; Mary M Lee; E A Catlin; P L Hudson; J Wing; David T MacLaughlin; Patricia K Donahoe
Developmental expression of a candidate müllerian inhibiting substance type II receptor.
Endocrinology 1996;137(1):160-5.